Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01207908
What this trial is testing

Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Children's Hospital Medical Center, Cincinnati 44
Testing effectiveness (Phase 2)Looking for participantsNCT06263543
What this trial is testing

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

Who this might be right for
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+2 more
Reshma L. Mahtani, D.O. 75
Not applicableStudy completedNCT06220877
What this trial is testing

Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study

Who this might be right for
Healthy Volunteers Only
October 6 University 24
Early research (Phase 1)Study completedNCT06115902
What this trial is testing

TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 153
Testing effectiveness (Phase 2)UnknownNCT00622726
What this trial is testing

Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
The University of Texas Health Science Center, Houston 150
Not applicableAvailableNCT07675057
What this trial is testing

Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisCarcinoma, Transitional Cell
Eli Lilly and Company
Not applicableStudy completedNCT00595595
What this trial is testing

Development of a Model to Evaluate Regenerative Endodontic Techniques Using Extract Human Teeth

Who this might be right for
Dental Pulp RegenerationDental Pulp Diseases
The University of Texas Health Science Center at San Antonio 1,080
Not applicableNot Yet RecruitingNCT06641245
What this trial is testing

PREconception Folic Acid Clinical Efficacy (PREFACE) Trial

Who this might be right for
FolateFolate BioavailabilityClinical Trials+1 more
University of British Columbia 272
Early research (Phase 1)Study completedNCT04820439
What this trial is testing

Pharmacokinetic Study of Recombinant Monoclonal Antibody Against Human Epidermal Growth Factor Receptor Injection

Who this might be right for
Healthy Volunteers
The Affiliated Hospital of Qingdao University 88
Not applicableStudy completedNCT01002872
What this trial is testing

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease

Who this might be right for
Metabolic Bone Disease
Endeavor Health 19
Very early researchNot Yet RecruitingNCT07498595
What this trial is testing

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Not applicableUnknownNCT02198001
What this trial is testing

Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction

Who this might be right for
Bisphosphonate-Associated Osteonecrosis of the Jaw
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 100
Large-scale testing (Phase 3)Study completedNCT00049543
What this trial is testing

Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
National Cancer Institute (NCI) 503
Not applicableStudy completedNCT02777567
What this trial is testing

KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 315
Not applicableStudy completedNCT03562819
What this trial is testing

Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
AstraZeneca 268
Post-approval studies (Phase 4)Ended earlyNCT01222819
What this trial is testing

SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients

Who this might be right for
Leukemia
Rabin Medical Center 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05637216
What this trial is testing

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Who this might be right for
Radiation Induced Fibrosis
Shaw Cancer Center 43
Not applicableStudy completedNCT05735392
What this trial is testing

Liquid Biopsy: Intercepting Mutational Trajectories of HER2 (Human Epidermal Growth Factor Receptor 2) Breast Cancer (GIM21 Trial)

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 48
Not applicableStudy completedNCT04916509
What this trial is testing

Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region

Who this might be right for
Breast Neoplasms
Pfizer 258
Not applicableStudy completedNCT07265804
What this trial is testing

PRF and CGF Scaffolds With EDTA in Regeneration

Who this might be right for
Pulp NecrosisImmature Permanent TeethOpen Apex+2 more
Kahramanmaras Sutcu Imam University 30
Next Page